AVDL
Avadel Pharmaceuticals plc
Company Overview
| Mkt Cap | $1.81B | Price | $18.89 |
| Volume | 3.18M | Change | +0.32% |
| P/E Ratio | -37.0 | Open | $18.80 |
| Revenue | $169.1M | Prev Close | $18.83 |
| Net Income | $-48.8M | 52W Range | $6.38 - $19.06 |
| Div Yield | N/A | Target | $18.89 |
| Overall | 59 | Value | 40 |
| Quality | 55 | Technical | 83 |
No chart data available
Stock Overview
Updated DailyAvadel Pharmaceuticals plc (AVDL) is a leading Healthcare company in the Biotechnology industry, currently trading at $18.89 with a market capitalization of $1.81 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows AVDL with a volume of 3.18 million shares. The stock opened down 0.16% from yesterday's close of $18.83. Current analyst estimates project earnings of $0.19 per share for this year, with next year targeting $0.82.
AVDL demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OCUP, NXEN, NVS, ODTC.
Key investment considerations for AVDL include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of 0.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 09:49 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVDL | $18.89 | +0.3% | 3.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Avadel Pharmaceuticals plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW